Central serous chorioretinopathy (CSCR)2020-01-23T18:40:52+01:00

STUDY AREAS/SCIENTIFIC RESEARCH – Central serous chorioretinopathy (CSCR)

WHAT IS IT AND HOW TO RECOGNISE IT

CENTRAL SEROUS CHORIORETINOPATHY (CSCR) is an eye disorder directly associated with stress. It mostly affects people who have a hyperactive personality, or who are very competitive or exposed to prolonged stress. Particularly introverted individuals, who have personality disorders and tend to isolate themselves from social relationships, also seem to be susceptible to CSCR.

Some risk factors: emotional and physical stress, high levels of blood cortisol.

The people most affected are male and aged between 25 and 55 years. When you find it in women it is usually the result of cortisol-based therapies or conditions that increase blood cortisol.

Central serous chorioretinopathy is usually not a serious disease that can cause great concern for those who suffer from it. It is characterised by the presence of foci of inflammation on the surface of the retina.

In CSCR a collection of fluid appears below the central portion of the retina (macula) without there being associated chorioretinal diseases. The symptoms involve blurred vision, presence of central dots, distorted images.

The condition can disappear spontaneously in 2-4 months with complete recovery of sight. It can however relapse and become chronic.

WE RECOMMEND

ALWAYS ASK YOUR OPHTHALMOLOGIST

FURTHER INFORMATION

RECOMMENDED PRODUCT

PRODUCT FEATURES
Le informazioni, immagini, descrizioni e quanto altro riportato nel sito relativi a dispositivi medici non sono di natura pubblicitaria ma materiale informativo rivolto esclusivamente a Professionisti dell’area sanitaria. Pertanto proseguendo nella navigazione l’utente dichiara di essere un Professionista dell’area sanitaria. Riferimento:Ministero della Salute – “Nuove linee guida della pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici” del 28 Marzo 2013; Aggiornamento delle “Linee guida in merito all’utilizzo di nuovi mezzi di diffusione della pubblicità sanitaria” del 17 Febbraio 2010 - These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Please contact your healthcare professional immediately if you experience any unwanted side effects. The information contained herein is for informational purposes only and does not establish a doctor-patient relationship. Please be sure to consult your physician before taking this or any other product. Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.